首页> 外文期刊>Breast care >Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients
【24h】

Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients

机译:加强监测以早期发现高危患者中的乳腺癌

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Efforts for early detection of breast cancer play an important role in the care of high-risk women. This will include both women with a pathological mutation in one of the known breast cancer susceptibility genes as well as women with a high breast cancer risk based on family history only. Due to the much higher incidence of breast cancer in premenopausal women with a genetic predisposition or a familial background, to be most effective, imaging-based breast surveillance should start at an age as early as 25-30 years. There is now ample evidence that magnetic resonance imaging (MRI) is by far the most sensitive imaging modality in young high-risk women. With high-risk multimodality screening at least 30% of breast cancers will be detected primarily by MRI and would have been missed at regular screening without MRI. Therefore, most high-risk breast surveillance programs now offer annual MRI to eligible high-risk women from age 25 to 30, usually supplemented by regular mammography starting at least from age 40. The inclusion of clinical breast exam (CBE) and/or ultrasound in the high-risk surveillance has little impact on the detection of additional cancers, but may improve compliance and reduce unnecessary call-backs for nonspecific findings on MRI. To reduce advanced stage interval cancers, especially in BRCA1/2 mutation carriers, some programs offer additional semiannual CBE and/or ultrasound or alternate MRI and mammography every 6 months. How long regular MRI should be continued in high-risk women is a matter of considerable debate. It appears feasible that MRI can safely be discontinued even in BRCA1/2 mutation carriers between the age of 60 and 70, especially if mammographic breast density is low. Even though several cohort studies have now demonstrated a very favorable stage distribution of breast cancers found in women undergoing high-risk surveillance with MRI, data on long-term survival and mortality in these patients is still rare.
机译:尽早发现乳腺癌的努力在高危妇女的护理中起着重要作用。这将包括在已知的乳腺癌易感性基因之一中发生病理突变的女性,以及仅根据家族史就具有较高乳腺癌风险的女性。由于具有遗传易感性或家族背景的绝经前妇女中乳腺癌的发生率要高得多,因此,要获得最有效的效果,基于影像的乳腺癌监测应从25-30岁开始。现在有足够的证据表明,磁共振成像(MRI)是迄今为止在高危年轻女性中最敏感的成像方式。通过高风险的多模式筛查,至少有30%的乳腺癌将主要通过MRI检出,而在没有MRI的常规筛查中会漏诊。因此,现在,大多数高危乳房监视程序都会为25岁至30岁的合格高危女性提供年度MRI检查,通常至少从40岁开始定期进行乳房X线检查。包括临床乳腺检查(CBE)和/或超声检查高风险监视中的MRI对其他癌症的检测几乎没有影响,但可以提高依从性并减少对MRI非特异性发现的不必要的回叫。为了减少晚期癌症,特别是在BRCA1 / 2突变携带者中,某些程序每6个月提供额外的半年度CBE和/或超声检查或交替进行MRI和X线摄影。高危女性应继续定期进行MRI多长时间是一个有争议的问题。即使在60至70岁之间的BRCA1 / 2突变携带者中也可以安全地中断MRI,尤其是在乳房X线照相的乳房密度较低的情况下,这似乎是可行的。尽管现在已有几项队列研究表明,在接受MRI高风险监测的女性中,乳腺癌的分期分布非常有利,但这些患者的长期生存率和死亡率数据仍然很少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号